Ticker name:CTORCITIUS ONCOLOGY, INC.

Country: US-Sector: Healthcare, Industry: Drug Manufacturers - General

Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.

Market Cap 95M

Last close 1.02$

Key metrics

Largest 18 companies In Drug Manufacturers - General

# PositionTickerCompany NameMarket CapLast PriceAction
1LLYELI LILLY & Co1.1T1152.44$
2JNJJOHNSON & JOHNSON651B270.22$
3ABBVAbbVie Inc.467B264.02$
4MRKMerck & Co., Inc.363B147.15$
5NVSNOVARTIS AG269B140.92$
6AZNASTRAZENECA PLC258B166.14$
7AMGNAMGEN INC205B379.78$
8GILDGILEAD SCIENCES, INC.187B150.89$
9PFEPFIZER INC158B27.64$
10BMYBRISTOL MYERS SQUIBB CO128B62.84$
11SNYSanofi105B43.14$
12BIIBBIOGEN INC.32B219.05$
13ZTSZoetis Inc.30B73.02$
14OGNOrganon & Co.3.6B13.69$
15CTORCITIUS ONCOLOGY, INC.95M1.02$
16SCLXScilex Holding Co46M5.37$
17SRXHSRX Global Inc.33M1.62$
18MIRAMIRA PHARMACEUTICALS, INC.32M0.7593$